Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro
- PMID: 9233783
- DOI: 10.1038/sj.onc.1201142
Inhibition of cyclin D expression in human breast carcinoma cells by retinoids in vitro
Abstract
Transfection and transgenic mouse experiments supported an oncogenic role for cyclin D1 in breast cancer. We recently reported that noninvasive carcinoma in situ lesions of the human breast overexpress cyclin D, suggesting that this molecular event may represent a valuable target for chemoprevention. The purpose of the present series of investigations was to identify agents which could reduce the cyclin D expression of breast cells. We report that 9-cis retinoic acid (9-cis RA) and all trans retinoic acid (tRA) inhibited the cyclin D1 and D3 expression levels of human MCF-7, ZR-75 and T-47D breast carcinoma cells in vitro. Where detectable, similar trends were observed in the immortalized, HBL-100 and MCF-10A breast cell lines. Cyclin D2 was undetectable. The effect of retinoids was both dose- and time-dependent, and correlated with altered cell cycle kinetics and proliferative status. Retinoids were also found to inhibit the expression levels of other cell cycle related proteins, including Cdk2 and Cdk4, resulting in lower kinase activities. In contrast to other breast prevention studies, no synergistic effect was observed with retinoids and tamoxifen. The data indicate that retinoids can potently reduce cyclin D expression levels in a variety of breast cell lines in vitro, and suggest further consideration of this mechanism for the chemoprevention of breast cancer.
Similar articles
-
Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.Exp Cell Res. 1997 Aug 1;234(2):293-9. doi: 10.1006/excr.1997.3589. Exp Cell Res. 1997. PMID: 9260897
-
Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.Anticancer Res. 2001 Jan-Feb;21(1A):413-20. Anticancer Res. 2001. PMID: 11299771
-
Ectopic expression of cyclin D1 amplifies a retinoic acid-induced mitochondrial death pathway in breast cancer cells.Oncogene. 2001 Jun 14;20(27):3506-18. doi: 10.1038/sj.onc.1204453. Oncogene. 2001. PMID: 11429697
-
Cyclins and breast cancer.Breast Cancer Res Treat. 1998;52(1-3):17-28. doi: 10.1023/a:1006102916060. Breast Cancer Res Treat. 1998. PMID: 10066069 Review.
-
Retinoid mechanisms and cyclins.Curr Oncol Rep. 2001 Jul;3(4):301-5. doi: 10.1007/s11912-001-0081-9. Curr Oncol Rep. 2001. PMID: 11389813 Review.
Cited by
-
Lycopene inhibition of IGF-induced cancer cell growth depends on the level of cyclin D1.Eur J Nutr. 2006 Aug;45(5):275-82. doi: 10.1007/s00394-006-0595-x. Epub 2006 Mar 24. Eur J Nutr. 2006. PMID: 16565789
-
A novel knowledge-driven systems biology approach for phenotype prediction upon genetic intervention.IEEE/ACM Trans Comput Biol Bioinform. 2011 Sep-Oct;8(5):1170-82. doi: 10.1109/TCBB.2011.18. IEEE/ACM Trans Comput Biol Bioinform. 2011. PMID: 21282866 Free PMC article.
-
Discovering transcription factor regulatory targets using gene expression and binding data.Bioinformatics. 2012 Jan 15;28(2):206-13. doi: 10.1093/bioinformatics/btr628. Epub 2011 Nov 13. Bioinformatics. 2012. PMID: 22084256 Free PMC article.
-
The low-toxicity 9-cis UAB30 novel retinoid down-regulates the DNA methyltransferases and has anti-telomerase activity in human breast cancer cells.Int J Oncol. 2007 Mar;30(3):641-50. Int J Oncol. 2007. PMID: 17273765 Free PMC article.
-
Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms.Mol Cancer. 2010 Jan 26;9:15. doi: 10.1186/1476-4598-9-15. Mol Cancer. 2010. PMID: 20102612 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
